Table of Content

1 Executive Summary


2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions


3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19


4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry


5 Global Ankylosing Spondylitis Market, By Molecule Type
5.1 Introduction
5.2 Biologics
5.3 Biosimilars
5.4 Small Molecules


6 Global Ankylosing Spondylitis Market, By Route of Administration
6.1 Introduction
6.2 Oral
6.3 Parenteral


7 Global Ankylosing Spondylitis Market, By Dosage Form
7.1 Introduction
7.2 Liquid
7.3 Solid


8 Global Ankylosing Spondylitis Market, By Drug
8.1 Introduction
8.2 Cimzia
8.3 Cosentyx
8.4 Enbrel
8.5 Humira
8.6 Remicade
8.7 Simponi


9 Global Ankylosing Spondylitis Market, By Drug Type
9.1 Introduction
9.2 Anti-Inflammatory Drugs
9.3 COX Inhibitors
9.4 Disease-Modifying Anitrheumatic Drugs (DMARDs)
9.5 Immunosuppressive Drugs
9.6 JAK Inhibitors
9.7 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
9.8 Steroids
9.9 TNF Inhibitors
9.10 IL-17 Inhibitors


10 Global Ankylosing Spondylitis Market, By Treatment Type
10.1 Introduction
10.2 Medication
10.3 Surgery
10.4 Therapy


11 Global Ankylosing Spondylitis Market, By Application
11.1 Introduction
11.2 Adults
11.3 Juveniles


12 Global Ankylosing Spondylitis Market, By End User
12.1 Introduction
12.2 Hospital
12.3 Care Home
12.4 Clinic


13 Global Ankylosing Spondylitis Market, By Geography
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 Germany
13.3.2 UK
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia Pacific
13.4.1 Japan
13.4.2 China
13.4.3 India
13.4.4 Australia
13.4.5 New Zealand
13.4.6 South Korea
13.4.7 Rest of Asia Pacific
13.5 South America
13.5.1 Argentina
13.5.2 Brazil
13.5.3 Chile
13.5.4 Rest of South America
13.6 Middle East & Africa
13.6.1 Saudi Arabia
13.6.2 UAE
13.6.3 Qatar
13.6.4 South Africa
13.6.5 Rest of Middle East & Africa


14 Key Developments
14.1 Agreements, Partnerships, Collaborations and Joint Ventures
14.2 Acquisitions & Mergers
14.3 New Product Launch
14.4 Expansions
14.5 Other Key Strategies


15 Company Profiling
15.1 Abbvie
15.2 Amgen
15.3 Boehringer Ingelheim
15.4 Bristol-Myers Squibb
15.5 Celgene
15.6 Celltrion
15.7 Eisai
15.8 Eli Lilly and Company
15.9 F. Hoffmann-La Roche
15.10 Janssen Pharmaceuticals
15.11 Johnson & Johnson Services, Inc
15.12 Merck & Co
15.13 Novartis AG
15.14 Pfizer
15.15 Regeneron Pharmaceuticals
15.16 Sanofi
15.17 Shanghai Pharmaceuticals
15.18 UCB, Inc

List of Tables
Table 1 Global Ankylosing Spondylitis Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Ankylosing Spondylitis Market Outlook, By Molecule Type (2018-2027) ($MN)
Table 3 Global Ankylosing Spondylitis Market Outlook, By Biologics (2018-2027) ($MN)
Table 4 Global Ankylosing Spondylitis Market Outlook, By Biosimilars (2018-2027) ($MN)
Table 5 Global Ankylosing Spondylitis Market Outlook, By Small Molecules (2018-2027) ($MN)
Table 6 Global Ankylosing Spondylitis Market Outlook, By Route of Administration (2018-2027) ($MN)
Table 7 Global Ankylosing Spondylitis Market Outlook, By Oral (2018-2027) ($MN)
Table 8 Global Ankylosing Spondylitis Market Outlook, By Parenteral (2018-2027) ($MN)
Table 9 Global Ankylosing Spondylitis Market Outlook, By Dosage Form (2018-2027) ($MN)
Table 10 Global Ankylosing Spondylitis Market Outlook, By Liquid (2018-2027) ($MN)
Table 11 Global Ankylosing Spondylitis Market Outlook, By Solid (2018-2027) ($MN)
Table 12 Global Ankylosing Spondylitis Market Outlook, By Drug (2018-2027) ($MN)
Table 13 Global Ankylosing Spondylitis Market Outlook, By Cimzia (2018-2027) ($MN)
Table 14 Global Ankylosing Spondylitis Market Outlook, By Cosentyx (2018-2027) ($MN)
Table 15 Global Ankylosing Spondylitis Market Outlook, By Enbrel (2018-2027) ($MN)
Table 16 Global Ankylosing Spondylitis Market Outlook, By Humira (2018-2027) ($MN)
Table 17 Global Ankylosing Spondylitis Market Outlook, By Remicade (2018-2027) ($MN)
Table 18 Global Ankylosing Spondylitis Market Outlook, By Simponi (2018-2027) ($MN)
Table 19 Global Ankylosing Spondylitis Market Outlook, By Drug Type (2018-2027) ($MN)
Table 20 Global Ankylosing Spondylitis Market Outlook, By Anti-Inflammatory Drugs (2018-2027) ($MN)
Table 21 Global Ankylosing Spondylitis Market Outlook, By COX Inhibitors (2018-2027) ($MN)
Table 22 Global Ankylosing Spondylitis Market Outlook, By Disease-Modifying Anitrheumatic Drugs (DMARDs) (2018-2027) ($MN)
Table 23 Global Ankylosing Spondylitis Market Outlook, By Immunosuppressive Drugs (2018-2027) ($MN)
Table 24 Global Ankylosing Spondylitis Market Outlook, By JAK Inhibitors (2018-2027) ($MN)
Table 25 Global Ankylosing Spondylitis Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (2018-2027) ($MN)
Table 26 Global Ankylosing Spondylitis Market Outlook, By Steroids (2018-2027) ($MN)
Table 27 Global Ankylosing Spondylitis Market Outlook, By TNF Inhibitors (2018-2027) ($MN)
Table 28 Global Ankylosing Spondylitis Market Outlook, By IL-17 Inhibitors (2018-2027) ($MN)
Table 29 Global Ankylosing Spondylitis Market Outlook, By Treatment Type (2018-2027) ($MN)
Table 30 Global Ankylosing Spondylitis Market Outlook, By Medication (2018-2027) ($MN)
Table 31 Global Ankylosing Spondylitis Market Outlook, By Surgery (2018-2027) ($MN)
Table 32 Global Ankylosing Spondylitis Market Outlook, By Therapy (2018-2027) ($MN)
Table 33 Global Ankylosing Spondylitis Market Outlook, By Application (2018-2027) ($MN)
Table 34 Global Ankylosing Spondylitis Market Outlook, By Adults (2018-2027) ($MN)
Table 35 Global Ankylosing Spondylitis Market Outlook, By Juveniles (2018-2027) ($MN)
Table 36 Global Ankylosing Spondylitis Market Outlook, By End User (2018-2027) ($MN)
Table 37 Global Ankylosing Spondylitis Market Outlook, By Hospital (2018-2027) ($MN)
Table 38 Global Ankylosing Spondylitis Market Outlook, By Care Home (2018-2027) ($MN)
Table 39 Global Ankylosing Spondylitis Market Outlook, By Clinic (2018-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.